Advertisement

Related Videos

Opportunities to Optimize Cancer Policies Panel Discussion

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Advertisement

Advertisement




Nov
19
Today In Oncology
Study Finds Personalized Risk Messages Had No Effect in Raising Colorectal Cancer Screening Participation
My 50 Years in Lymphoma: Lessons Learned?
Does Kidney Stone History Impact Survival Outcomes in Upper Tract Urothelial Carcinoma
Active Surveillance With Metformin vs Placebo in Low-Risk Prostate Cancer
Izalontamab Brengitecan in Recurrent or Metastatic Nasopharyngeal Carcinoma
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo